Endpoints News

AnaptysBio spins out biotech operations; Affibody’s data in hidradenitis suppurativa

Published

2 weeks ago

on

Plus, news about Zenas and Ysios Capital:

🌀 AnaptysBio’s spinout: The independent public company, called First Tracks Biotherapeutics, is expected to start trading on April 20. It will launch with …

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version